Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Roystonea regia lipid extract reduces lower urinary tract symptoms in men with BPH

July 26, 2019

Regulus outlines FDA requirements to reinitiate MAD studies with RGLS-4326

July 24, 2019

BioMarin Pharmaceutical identifies hydroxyacid oxidase 1 inhibitors

July 24, 2019

DiaMedica reports phase Ib interim data on DM-199 in chronic kidney disease

June 20, 2019

Arch Biopartners initiates phase I study of Metablok

June 20, 2019

Corvidia opens phase II study of ziltivekimab to reduce inflammation in chronic renal disease

June 14, 2019

RNA triad prevents dialysis-induced fibrosis

June 14, 2019

Increased CCL14 expression linked to chronic kidney disease

June 13, 2019

Positive topline results presented for phase II study of Gazyva in lupus nephritis

June 11, 2019

Goldfinch begins first-in-human study of GFB-887 for kidney disease

June 7, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...